-
341
Lung Cancer Prediction Using Neural Network Ensemble with Histogram of Oriented Gradient Genomic Features
Published 2015-01-01“…These machine learning classifiers were trained to predict lung cancer using samples of patient nucleotides with mutations in the epidermal growth factor receptor, Kirsten rat sarcoma viral oncogene, and tumor suppressor p53 genomes collected as biomarkers from the IGDB.NSCLC corpus. …”
Get full text
Article -
342
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
Published 2025-02-01“…The Kirsten rat sarcoma (KRAS) oncogene was considered “undruggable” until the development of sotorasib, a KRASG12C selective inhibitor that shows favorable effects against lung cancers. …”
Get full text
Article -
343
Molecular and Phylogenetic Analysis of Bovine Papillomavirus Type 1: First Report in Iraqi Cattle
Published 2016-01-01“…BPV is a widely spread oncogenic virus in Iraqi cattle and is associated with the formation of both benign and malignant lesions, resulting in notable economic losses in dairy and beef cattle. …”
Get full text
Article -
344
MicroRNA-877-5p Inhibits Cell Progression by Targeting FOXM1 in Lung Cancer
Published 2022-01-01“…Many researches revealed that microRNAs (miRNAs) function as potential oncogene or tumor suppressor gene. As an antioncogene, miR-877-5p was reduced in many tumors. …”
Get full text
Article -
345
Pharmacological activity of OST-01, a natural product from baccharis coridifolia, on breast cancer cells
Published 2025-02-01“…OST-01 significantly inhibited cell proliferation and oncogenic activities of TNBC cells in vitro. OST-01 also markedly inhibited TNBC tumor growth in vivo, with > 50% reduction in tumor size compared to vehicle control treatment in different in vivo models, i.e., cell line-derived (CDX), patient-derived (PDX), and mammary fat pad xenografts. …”
Get full text
Article -
346
Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation
Published 2025-01-01“…Furthermore, MT-CO2 is indispensable for oncogenic Ras-induced glutaminolysis and tumor growth, and elevated expression of MT-CO2 is associated with poor prognosis in lung cancer patients. …”
Get full text
Article -
347
Melanoma genomics – will we go beyond BRAF in clinics?
Published 2024-09-01“…However, evaluating the oncogene BRAF mutation in codon V600 is still the only companion diagnostic genomic test commonly implemented in clinics for molecularly targeted treatment of advanced melanoma. …”
Get full text
Article -
348
Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
Published 2025-02-01“…Dysregulated polyamine metabolism and its interaction with oncogenic pathways promote tumor progression. However, the heterogeneity of polyamine metabolism and its effects on the immune microenvironment and response to immunotherapy in HCC remain unclear. …”
Get full text
Article -
349
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors
Published 2025-02-01“…Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are found in 90% of PDAC cases, and tumors dependent on KRAS (dKRAS) can be identified using gene expression signature scores. …”
Get full text
Article -
350
Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
Published 2024-12-01“…The human T-lymphotropic virus type-1 (HTLV-1) is an oncogenic retrovirus that predominantly spreads through cell-to-cell contact due to the limited infectivity of cell-free viruses. …”
Get full text
Article -
351
Dysbiosis and extraintestinal cancers
Published 2025-02-01“…The dissemination of pathogens through the circulation may contribute to the establishment of an immune-suppressive environment that promotes carcinogenesis in extraintestinal organs either directly or indirectly. The oncogenic cascade always engages in the disruption of hormonal regulation and inflammatory responses, the induction of genomic instability and mutations, and the dysregulation of adult stem cell proliferation. …”
Get full text
Article -
352
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor
Published 2020-01-01“…In this report, we also discuss the oncogenic potential of BK virus, the use of checkpoint inhibitors in urothelial carcinoma, and the feasibility of retransplant for this patient population.…”
Get full text
Article -
353
Transmembrane Amino Acid Transporters in Shaping the Metabolic Profile of Breast Cancer Cell Lines: The Focus on Molecular Biological Subtype
Published 2024-12-01“…In addition to the main signaling pathway PI3K/Akt/mTOR, the activity of the oncogene c-Myc, HIF, p53, GATA2, NF-kB and MAT2A have a direct effect on the amino acid metabolism of cancer cells, their growth and proliferation, as well as the maintenance of homeostatic equilibrium. …”
Get full text
Article -
354
The crosstalk between SND1 and PDCD4 is associated with chemoresistance of non-small cell lung carcinoma cells
Published 2025-01-01“…Previously, we demonstrated the oncogenic role of Tudor Staphylococcal nuclease (TSN, also known as Staphylococcal nuclease domain-containing protein 1, SND1), in regulating chemoresistance in NSCLC cells. …”
Get full text
Article -
355
GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells
Published 2025-01-01“…Epidermal growth factor receptor (EGFR) is a major oncogenic protein, and thus EGFR-targeting therapies are widely used in patients with various types of cancer, including lung cancer. …”
Get full text
Article -
356
FBXW7 Reduces the Cancer Stem Cell-Like Properties of Hepatocellular Carcinoma by Regulating the Ubiquitination and Degradation of ACTL6A
Published 2022-01-01“…The in vivo ubiquitination assay showed that FBXW7 repressed HCC malignancy by regulating the oncogenic activity of ACTL6A in a ubiquitin-dependent manner. …”
Get full text
Article -
357
Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas
Published 2025-01-01“…The exploration extends to the potential of targeting circRNAs as a novel cancer therapy strategy, either through inhibiting oncogenic circRNAs or reinstating tumor-suppressive ones. …”
Get full text
Article -
358
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma
Published 2025-03-01“…While this factor is known to cooperate with the proto-oncogene MYC during malignant B cell development, the effect of interfering with both factors remains underexplored. …”
Get full text
Article -
359
Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL
Published 2025-01-01“…Moreover, our investigation identified FUT8, a fucosyltransferase, as a potential target for morusinol. FUT8’s role as an oncogene in DLBCL and its correlation with poor survival further underscored its significance. …”
Get full text
Article -
360
Vitamin C exerts anti-cadmium induced fracture functions/targets: bioinformatic and biostructural findings
Published 2022-09-01“…Nine core targets were characterized, including tumor protein p53, epidermal growth factor receptor, proto-oncogene c, mitogen-activated protein kinase-1 (MAPK1), MAPK3, signal transducer and activator of transcription-3, MAPK14, prostaglandin-endoperoxide synthase 2, and estrogen receptor alpha. …”
Get full text
Article